What is Wobble Genomics?
Wobble Genomics specializes in enhancing RNA and DNA sequencing efficiency, a critical function for the discovery and detection of nucleic acid biomarkers. By integrating advanced biochemistry with sophisticated bioinformatics, the company delivers comprehensive solutions to its clientele. This dual approach allows for precise analysis and interpretation of genetic data, positioning Wobble Genomics as a key player in the genomics and biotechnology landscape.
How much funding has Wobble Genomics raised?
Wobble Genomics has raised a total of $12.4M across 2 funding rounds:
Angel/Seed
$1.6M
Other Financing Round
$10.8M
Angel/Seed (2021): $1.6M with participation from Eos Advisory
Other Financing Round (2024): $10.8M led by Old College Capital, BGF, IQ Capital, and EOS Advisors
Key Investors in Wobble Genomics
Old College Capital
Old College Capital (OCC) is the University of Edinburgh's venture investment fund, supporting high-growth, early-stage businesses associated with the university, indicating a focus on academic innovation.
BGF
BGF is a prominent UK investor focused on small and mid-sized businesses, supporting companies across various stages of growth and sectors, suggesting a strategic interest in established, scalable enterprises.
IQ Capital
IQ Capital is a venture capital firm specializing in 'deep-tech' investments, including AI, machine learning, and data-focused propositions, indicating a strong inclination towards disruptive, globally scalable technologies.
What's next for Wobble Genomics?
The recent major strategic investment suggests Wobble Genomics is poised for an expansion phase, likely focusing on scaling its operations, advancing its technological platform, and potentially broadening its market reach. The company's focus on biomarker discovery aligns with the growing demand for personalized medicine and advanced diagnostics. Future developments may include strategic partnerships or further research and development to solidify its competitive edge in the rapidly evolving life sciences industry.
See full Wobble Genomics company page
